Systematic review of studies of productivity loss due to rheumatoid arthritis

被引:211
作者
Burton, W
Morrison, A
Maclean, R
Ruderman, E
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] SCRIBCO, Blue Bell, PA USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
来源
OCCUPATIONAL MEDICINE-OXFORD | 2006年 / 56卷 / 01期
关键词
economics; employment; epidemiology; rheumatoid arthritis; risk factors;
D O I
10.1093/occmed/kqi171
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Rheumatoid arthritis (RA) is a chronic, debilitating disease with a significant impact on workplace productivity. Aim To perform a systematic review of studies of the relationship between RA and reduced workplace productivity. Methods Screening of 307 titles identified in bibliographic database searches resulted in 38 articles subject to systematic review. Productivity loss was expressed by three different measures: work disability, work loss (synonymous with absenteeism or short-term sick leave) and work limitation (reduction in productivity while present at work). Results A median of 66% (range 36-84%) of employed RA subjects experienced work loss due to RA in the previous 12 months, for a median duration of 39 days (range 7-84 days). The times from RA diagnosis until a 50% probability of being work disabled varied from 4.5 to 22 years. In inception cohort studies, the baseline variables consistently predictive of subsequent work disability were a physically demanding work type, more severe RA and older age. Conclusions RA-related work-disability rates were similar in the USA and European countries. An apparent decrease in the prevalence of RA-related work disability since the 1970s may be related to a decrease in physically demanding work rather than to epidemiologic changes in RA. The majority of the literature addresses permanent disability and temporary work loss; none of the studies reviewed reported the effect of RA on presenteeism, i.e. work limitation from the employer perspective, and there are few published studies of the effectiveness of disease-modifying anti-rheumatic drugs in reducing work-related productivity loss.
引用
收藏
页码:18 / 27
页数:10
相关论文
共 90 条
  • [1] Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis
    AbdelNasser, AM
    Rasker, JJ
    Valkenburg, HA
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1997, 27 (02) : 123 - 140
  • [2] Socio-economic consequences of rheumatoid arthritis in the first years of the disease
    Albers, JMC
    Kuper, HH
    van Riel, PLCM
    Prevoo, MLL
    Van't Hof, MA
    van Gestel, AM
    Severens, JL
    [J]. RHEUMATOLOGY, 1999, 38 (05) : 423 - 430
  • [3] Allaire S H, 1996, Arthritis Care Res, V9, P349, DOI 10.1002/1529-0131(199610)9:5<349::AID-ANR1790090503>3.0.CO
  • [4] 2-G
  • [5] Update on work disability in rheumatic diseases
    Allaire, SH
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2001, 13 (02) : 93 - 98
  • [6] THE COSTS OF RHEUMATOID-ARTHRITIS
    ALLAIRE, SH
    PRASHKER, MJ
    MEENAN, RF
    [J]. PHARMACOECONOMICS, 1994, 6 (06) : 513 - 522
  • [7] [Anonymous], MORBIDITY MORTALITY
  • [8] Employment and work disability in rheumatoid arthritis
    Backman, CL
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (02) : 148 - 152
  • [9] Backman CL, 2004, J RHEUMATOL, V31, P47
  • [10] The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study
    Barrett, EM
    Scott, DGI
    Wiles, NJ
    Symmons, DPM
    [J]. RHEUMATOLOGY, 2000, 39 (12) : 1403 - 1409